FSENX
Price
$82.90
Change
+$1.13 (+1.38%)
Updated
Jun 2 closing price
Net Assets
3.67B
HNRGX
Price
$38.41
Change
+$0.64 (+1.69%)
Updated
Jun 2 closing price
Net Assets
16.76M
Interact to see
Advertisement

FSENX vs HNRGX

Header iconFSENX vs HNRGX Comparison
Open Charts FSENX vs HNRGXBanner chart's image
FSENX vs HNRGX Comparison Chart in %
View a ticker or compare two or three
VS
FSENX vs. HNRGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSENX is a Buy and HNRGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 3.67B vs. HNRGX (16.8M). FSENX pays higher dividends than HNRGX: FSENX (1.63) vs HNRGX (0.42). FSENX was incepted earlier than HNRGX: FSENX (45 years) vs HNRGX (12 years). HNRGX (2.70) is less costly to investors than FSENX (0.65). HNRGX is a more actively managed with annual turnover of: 33.00 vs. FSENX (14.00). FSENX has a lower initial minimum investment than HNRGX: FSENX (0) vs HNRGX (2500). FSENX annual gain was more profitable for investors over the last year : 51.56 vs. HNRGX (40.84). FSENX return over 5 years is better than : 167.45 vs. HNRGX (151.71).
FSENXHNRGXFSENX / HNRGX
Total Expense Ratio0.652.5326%
Annual Report Gross Expense Ratio0.652.7024%
Fund Existence45 years12 years-
Gain YTD33.18425.440130%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.67B16.8M21,827%
Annual Yield % from dividends1.630.42385%
Returns for 1 year51.5640.84126%
Returns for 3 years67.1278.7485%
Returns for 5 years167.45151.71110%
Returns for 10 years135.28150.5390%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUGP1.070.05
+4.90%
SU Group Holdings Limited
BODI10.890.09
+0.83%
The Beachbody Company Inc
SNN29.36-0.12
-0.41%
Smith & Nephew plc
CLDX28.89-1.25
-4.15%
Celldex Therapeutics
WEAV6.03-0.45
-6.94%
Weave Communications